about
Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal modelTacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipientsPolyclonal and monoclonal antibodies for induction therapy in kidney transplant recipientsInterleukin 2 receptor antagonists for kidney transplant recipientsNew immunosuppressive drugs in heart transplantationA Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in EthiopiaRenal transplantationPolyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.Adverse effects of systemic immunosuppression in keratolimbal allograft.Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial dataCyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy.Transplantation tolerance: the concept and its applicability.Non-human to human organ transplantation: its biologic basis and a potential role for radiation therapy.Multiple costimulatory blockade in the peripheral nerve allograft.Challenges to achieving clinical transplantation tolerance.Membranous lupus nephritis in a renal allograft: response to mycophenolate mofetil therapy.Survival of living-related kidney graft recipients in the era of modern immunosuppressive treatment.Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltThe potential of antibody-based immunosuppressive agents for corneal transplantation.Apoptosis and transplantation tolerance.Novel views on new-onset diabetes after transplantation: development, prevention and treatment.Management of high-risk corneal grafts.Sirolimus-induced pneumonitis: three cases and a review of the literature.Inchingorei-san (TJ-117) and Artemisiae Capillaris Herba Induced Prolonged Survival of Fully Mismatched Cardiac Allografts and Generated Regulatory Cells in Mice.Dendritic cells as promoters of transplant tolerance.Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: A pilot study.Pharmacotherapy of allergic eye disease.Critical care perspective on immunotherapy in lung transplantation.From current immunosuppressive strategies to clinical tolerance of allografts.The CARI guidelines. Calcineurin inhibitors in renal transplantation: the addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients.Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival AnalysisDermal peptide delivery using colloidal carrier systems.The role of tacrolimus in renal transplantation.The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept.The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection.Induction immunosuppression for orthotopic heart transplantation: a review.Peritoneal dialysis in transplant recipient patients: outcomes and management.Primer on renal transplantation.Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients.Extended-release tacrolimus: a review of its use in de novo kidney transplantation.
P2860
Q21131365-E7D1C977-3CFC-4033-BAF7-763957F9D1C8Q24245456-A571D340-5478-4E3A-BC42-18390660A2A9Q24247263-80C30866-0526-457D-B544-02881AA283AFQ24247441-8C2DCCDC-7CFC-45AE-8591-A42FE8284747Q24793542-C3364746-639C-4212-B715-167EFC9E527FQ28551160-0099CFE7-8CDA-469A-AA94-F6036FCE765FQ28769695-60568BB4-4DB6-4724-A0F0-B912BF3126E9Q30239091-2505F9F0-DEE1-4BE7-864C-3D62FD512D73Q30468406-B6532E63-3312-4AC1-90C3-27ED94AA040DQ31004418-9AE385E7-C425-4843-86F9-AC72E510F388Q33338287-585D7440-7D59-495A-B7F0-7F1270DD01C4Q33732945-6E908908-F19B-4DEC-A9AB-0F64AD57CC72Q34210428-15B5E0D3-58A3-46D2-AED0-AFC32D009D2EQ34246339-DFCC416C-9103-4F4D-8B21-23F8365E0353Q34387873-EE276DAA-1383-405A-A215-BD48F5D412D5Q34725204-246CFF4B-41D1-41E8-B598-F0AB148E2436Q35059593-AA72865E-5C4D-4E04-AECD-4644109A0DD3Q35071614-7BEE5399-A718-41D8-92C5-A08572DCA078Q35083644-44B86E7D-FB35-4B2D-ACE6-5064C93A0F8EQ35129735-991B6693-9583-4438-93F7-D676E24345A9Q35221336-9A2A4B8D-3F75-42B3-93C5-52D1E256409CQ35590428-7B0716C5-5B0F-491C-8B41-A47EE02B8D74Q35608779-F37B4EA1-6E09-475D-A1E6-F606AEC1320BQ36090377-55261983-3A79-43DD-A7C7-B6EB88481A97Q36425922-DA1E6CCB-727A-41E3-A70B-3A2EDEC6805BQ36468653-83DF67B5-16CC-41B2-8F7D-5EE2CE722088Q36491809-E383D1E1-1336-45AD-A364-73177B2A0E3FQ36649380-1C77AC04-A0B6-45C3-B415-F7D98D245FFEQ36689232-8FF9781B-0687-4ADC-8410-47FE07638086Q36742542-DC52036D-3D6A-4428-B58F-2C2D1E8FC8B0Q36877834-E416A1DF-47C4-49E9-80A7-5D465F2A0E5DQ36958579-4FC78112-EC3A-4C42-8DAF-68AFFD07CA63Q37099023-1A92703B-E040-41A2-9BE3-8C7B65C97D01Q37586853-171EFECB-5633-4150-9543-85E8CEB5E660Q37614753-A5C33E10-3CC7-4862-B8E3-D325996D4FA6Q37668566-54C28199-0EAB-4DC6-A5A3-AB6ED7A21469Q37894113-5079F9AC-ADD0-4C20-B79F-B64A40B96FD6Q38016076-501A5593-C2EF-4B83-A9E6-09B65F4F71F5Q38063054-EE226356-7326-4FE4-B934-12E9109558EEQ38263466-F72B9D6C-9E06-4079-B621-C779543969B2
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Immunosuppressive strategies in transplantation.
@ast
Immunosuppressive strategies in transplantation.
@en
type
label
Immunosuppressive strategies in transplantation.
@ast
Immunosuppressive strategies in transplantation.
@en
prefLabel
Immunosuppressive strategies in transplantation.
@ast
Immunosuppressive strategies in transplantation.
@en
P2093
P1433
P1476
Immunosuppressive strategies in transplantation.
@en
P2093
P304
P356
10.1016/S0140-6736(98)07493-5
P407
P577
1999-03-01T00:00:00Z